Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Pre-existing risk factor … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: prospective cohort study in Gothenburg, Sweden

Artikel i vetenskaplig tidskrift
Författare Kerstin Rödström
Calle Bengtsson
Lauren Lissner
Cecilia Björkelund
Publicerad i British Medical Journal
Volym 319
Sidor 890-898
Publiceringsår 1999
Publicerad vid Institutionen för samhällsmedicin, Avdelningen för allmänmedicin
Sidor 890-898
Språk en
Länkar www.pubmedcentral.nih.gov/articlere...
Ämneskategorier Folkhälsomedicinska forskningsområden

Sammanfattning

Department of Primary Health Care, Vasa Hospital, Gothenburg University, SE-411 33 Gothenburg, Sweden. Kerstin.Rodstrom@allmed.gu.se OBJECTIVE: To assess whether risk factor profiles for cardiovascular disease differed, before starting treatment, between women who would subsequently use hormone replacement therapy and those who would remain untreated. DESIGN: Prospective population study, initiated in 1968-9, with follow ups in 1974, 1980, and 1992. SETTING: Gothenburg, Sweden. PARTICIPANTS: 1201 women born in 1918, 1922, and 1930, representative of women of the same age in the general population. MAIN OUTCOME MEASURES: Hormone replacement therapy as a function of initial systolic and diastolic blood pressure, waist and hip circumference, waist to hip ratio, body mass index, serum concentrations of cholesterol and triglycerides, smoking status, education, leisure time activity, and socioeconomic group. RESULTS: 179 of the 1202 women (14.9%) used hormone replacement therapy sometime during the 24 year follow up period. Age adjusted models indicated that these women had significantly lower blood pressure, had less obesity, and belonged to a higher social group before the start of treatment than women who would remain untreated [corrected]. CONCLUSION: Women who would subsequently use hormone replacement therapy were already at lower cardiovascular risk before the start of treatment than women who would remain untreated. Some of the claimed beneficial effects of treatment may thus be explained by women who would use hormone replacement therapy representing a healthier cohort than women who would remain untreated. PMID: 10506047 [PubMed - indexed for MEDLINE]

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?